Daily News

The biotech firm’s Phase 1/2 trial data for its gene-editing therapy BEAM-302 showed marked improvement in patients with AAT deficiency.

The AI-based entertainment company terminated its share sale agreement with Alliance Global Partners after selling around 5.9 million shares under the deal.

AEye caught retail attention after reporting a 110% increase in fourth-quarter revenue and joining NVIDIA's Halos AI Systems Inspection Lab to boost its lidar solutions.

Teladoc Health drew investor interest following a couple of bullish brokerage actions after peer Talkspace signed an acquisition agreement with Universal Health Services a day earlier.

The Chinese EV maker reported a 76% increase in fourth-quarter revenue, beating Wall Street estimates, according to Fiscal.ai data.

MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers.

The company announced the acquisition of a minority stake in an AI-infrastructure company in an all-stock deal.

Saudi Arabia has reportedly started cutting oil production as the escalating conflict in the Middle East saw critical energy infrastructure being targeted by both sides over the weekend.

The drone and wireless technology firm reaffirmed its 2026 revenue guidance of $170 million to $180 million.

The report states that the policy center will legalize perpetual derivatives and help regulators write DeFi guidelines for the financial system.

ARK Invest says tokenized assets could reach $11 trillion by 2030 as stablecoins, Ethereum, and institutions push finance on-chain.

Republican Congressman French Hill revealed that the market structure bill will “very soon” be on President Trump’s desk, after Republicans spent four years on it.

The JUP token is 89% below its $1.83 peak. However, the token is up 58.43% since its low.

Market-based odds now show an 87% chance of a rate cut.

Retail sentiment on SPY and QQQ stayed bearish as earnings news and after-hours swings drove action.